Search

everythinglearnresearchcommunity

for

Search:↓

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Doctors often diagnose Cushing's syndrome late, which worsens symptoms; earlier detection is needed.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

The case shows the difficulty in diagnosing certain conditions when standard tests are negative.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.